+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey



The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey



Archives of Dermatology 137(3): 280-284



Psoriasis can have a profound impact on a patient's quality of life. To assess patients' perspectives on the impact of psoriasis on their lifestyle and emotional well-being and the social ramifications of living with the disease; to determine the range of therapies available; and to ascertain patients' satisfaction with the management of their disease. A 4-page, self-administered questionnaire was mailed on July 13 and 14, 1998, to the entire membership of the National Psoriasis Foundation (N = 40 350), and followed by a telephone survey of responders with severe psoriasis. Patients' perspectives on the psychosocial impact of psoriasis and the effectiveness of the management of their disease. Of the 40 350 questionnaires mailed out, a response rate of 43% was realized. The most frequent symptoms experienced by the mail-survey respondents were scaling (94%), itching (79%), and skin redness (71%); 39% reported that psoriasis covered 10% or more of their bodies. A total of 6194 patients with severe psoriasis were entered into the database for the telephone survey. Of these, 79% reported that psoriasis had a negative impact on their lives, 40% felt frustrated with the ineffectiveness of their current therapies, and 32% reported that treatment was not aggressive enough. The unprecedented response to the survey provides compelling evidence that individuals with psoriasis believe that the disease has a profound emotional and social as well as physical impact on their quality of life. Many patients with psoriasis, particularly those with severe disease, are frustrated with the management of their disease and by the perceived ineffectiveness of their therapies. Physicians may need to improve communication with their patients and should reevaluate their management of psoriasis.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 047660085

Download citation: RISBibTeXText

PMID: 11255325


Related references

Quality of life and treatment satisfaction among patients with psoriasis and psoriatic arthritis and patients with psoriasis only : results of the 2005 Spring US National Psoriasis Foundation Survey. American Journal of Clinical Dermatology 9(2): 111-117, 2008

Quality of life and work productivity impairment among psoriasis patients: findings from the National Psoriasis Foundation survey data 2003-2011. Plos One 7(12): E52935, 2013

Disease burden and quality of life in psoriasis patients with and without comorbid psoriatic arthritis: results from National Psoriasis Foundation panel surveys. Cutis 95(3): 173-178, 2015

Are patients with psoriasis undertreated? Results of National Psoriasis Foundation survey. Journal of the American Academy of Dermatology 57(6): 957-962, 2007

Correlation of National Psoriasis Foundation score components with quality of life measures in psoriasis. Journal of Investigative Dermatology 121(1): 0357, 2003

Quality of life and contact with healthcare systems among patients with psoriasis and psoriatic arthritis: results from the NORdic PAtient survey of Psoriasis and Psoriatic arthritis (NORPAPP). Archives of Dermatological Research 311(5): 351-360, 2019

Quality of Life (Qol) With Psoriasis: Ethnography Study Evaluating the Impact of Psoriasis On Moderate To Severe Patients In Europe (Eu), From A Patient's Perspective. Value in Health 17(7): A538, 2014

Access to health care in patients with psoriasis and psoriatic arthritis: data from National Psoriasis Foundation survey panels. JAMA Dermatology 149(6): 717-721, 2013

Impact of brodalumab treatment on psoriasis symptoms and health-related quality of life: use of a novel patient-reported outcome measure, the Psoriasis Symptom Inventory. British Journal of Dermatology 170(3): 705-715, 2014

Psoriasis comorbidities: results from the National Psoriasis Foundation surveys 2003 to 2011. Dermatology 225(2): 121-126, 2012

Impact of ixekizumab on facial psoriasis and related quality of life measures in moderate-to-severe psoriasis patients: 12-week results from two phase III trials. Journal of the European Academy of Dermatology and Venereology 32(1): 68-72, 2018

From the Medical Board of the National Psoriasis Foundation: The risk of cardiovascular disease in individuals with psoriasis and the potential impact of current therapies. Journal of the American Academy of Dermatology 70(1): 168-177, 2014

European patient perspectives on the impact of psoriasis: the EUROPSO patient membership survey. British Journal of Dermatology 155(4): 729-736, 2006

Comparison of the National Psoriasis Foundation Psoriasis Score with psoriasis area and severity index. Journal of Investigative Dermatology 117(2): 546, 2001

The National Psoriasis Foundation Psoriasis Score (NPF-PS) system versus the Psoriasis Area Severity Index (PASI) and Physician's Global Assessment (PGA): a comparison. Journal of Drugs in Dermatology 2(3): 260-266, 2003